Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Diabetes Science and Technology|October 28, 2024
Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes CarePim Dekker, Tim van den Heuvel, Arcelia Arrieta, et al.Diabetes, Obesity & Metabolism|April 11, 2022
Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world usersArcelia Arrieta, Tadej Battelino, Andrea E Scaramuzza, et al.Diabetes, Obesity & Metabolism|May 7, 2021
Real-world performance of the MiniMed™ 670G system in EuropeJulien Da Silva, Emanuele Bosi, Johan Jendle, et al.Diabetes Technology & Therapeutics|February 20, 2024
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United StatesJames R Thrasher, Arcelia Arrieta, Fang Niu, et al.Diabetes, Obesity & Metabolism|February 5, 2025
MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targetsVittorino Smaniotto, Simon Heller, David O'Neal, et al.Journal of Diabetes Science and Technology|March 12, 2025
Performance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26 427 UsersIsabeau Thijs, Arcelia Arrieta, Javier Castañeda, et al.Diabetes, Obesity & Metabolism|February 15, 2023
Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery systemBruno Grassi, Ana Maria Gómez, Luis Eduardo Calliari, et al.Diabetes Technology & Therapeutics|March 6, 2024
Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian ExperienceBella Halim, Mary B Abraham, Georgina Manos, et al.Diabetes, Obesity & Metabolism|December 27, 2023
The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during RamadanMohammed E Al-Sofiani, Goran Petrovski, Abdulrahman Al Shaikh, et al.Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.Pageof 2